Rollan, Ayesha L.

HRN: 23-83-72  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/29/2025
CEFUROXIME 750MG (VIAL)
08/29/2025
09/05/2025
IV
270mg
Q8H
PCAP C
Checking Initial Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines